Sean McDonald

Sean McDonald is the current director at ImpriMed. Sean has also served as the president and CEO of Ocugenix, a developmental stage therapeutics company focused on diseases of the eye. McDonald has also been the acting president and CEO of SnapRetail / Snap-Rx, a technology company which offers tools for retail organizations which streamline their on-line marketing efforts. In addition, McDonald has served as a director for Aethon, a venture partner for Adams Capital Management, and the president and CEO of Precision Therapeutics. Sean has also been a director and member of the board for Respironics and a group president for McKesson.

Sean McDonald has a Bachelor's degree from the University of Pennsylvania in Chemical Engineering, which they obtained in 1982. Sean then went on to get their Master's in Computer Science Engineering from the University of Florida in 1985. Finally, they completed their MBA at Carnegie Mellon University's Tepper School of Business in 1987.